Contact us

Support


Home > Investment tools > They choose Russia > Shire Pharmaceuticals

Shire Pharmaceuticals

The Generium pharmaceutical company established a joint venture with Irish Shire Corporation. The new partners control already about 70% of the market of public procurement of medicines for hemophilia, the value of which has exceeded 8 bln rubles last year.

10 April 2017
Investor

Investor profile

Shire Pharmaceuticals

Ireland

Company's website: www.shire.com

T: +41 0 41 288 40 00

Public company

Contact: Flemming Ørnskov, General Director

A manufacturer of medicines for the treatment of rare diseases, the third-largest pharmaceutical producer in Britain

Subscribe to Newsletters

Email: